BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Marina Biotech, Inc. 


3830 Monte Villa Parkway
Bothell  Washington  98021  U.S.A.
Phone: 425-908-3600 Fax: 425-908-3650


SEARCH JOBS


Industry
Biotechnology






 Company News
Rosetta Genomics Ltd. (ROSG) And Marina Biotech, Inc. (MRNA) Establish Strategic Alliance To Jointly Develop microRNA-Based Diagnostics And Therapeutics For Rare Diseases 4/3/2014 10:22:07 AM    More...
Marina Biotech, Inc. (MRNA) To Use Its RNAi, Antisense And microRNA Therapeutics Platform To Develop Drugs For Rare Diseases 3/12/2014 9:14:10 AM    More...
Marina Biotech, Inc. (MRNA) Continues To Build Worldwide Patent Protection For Its SMARTICLES® Nucleic Acid Delivery Technology 2/28/2014 10:05:29 AM    More...
Marina Biotech, Inc. (MRNA) Announces $6 MM Convertible Preferred Stock Financing And Conversion To Common Stock Of The Company's Promissory Note 2/25/2014 10:01:45 AM    More...
Marina Biotech, Inc. (MRNA) Announces $6 Million Convertible Preferred Stock Financing And Conversion To Common Stock Of The Company's Promissory Note 2/24/2014 7:22:44 AM    More...
Marina Biotech, Inc. (MRNA) Achieves Broad Patent Coverage For DiLA2 Nucleic Acid Delivery Technology In U.S., Europe And Japan 1/24/2014 9:36:29 AM    More...
Marina Biotech, Inc. (MRNA) Strengthens The Intellectual Property Estate For The Transkingdom RNA Interference Nucleic Acid Delivery Technology 1/15/2014 8:31:48 AM    More...
Marina Biotech, Inc. (MRNA) Strengthens the Intellectual Property Estate For SMARTICLES® Nucleic Acid Delivery Technology 1/10/2014 6:34:22 AM    More...
Marina Biotech, Inc. (MRNA) Announces Sr. Management Shakeup 1/3/2014 8:32:35 AM    More...
Marina Biotech, Inc. And Mirna Therapeutics, Inc. Amend License Agreement For The Development Of microRNA-Based Therapeutics 1/2/2014 8:57:39 AM    More...
12345678910...

//-->